[{"Assets_0_Q3_USD":922512000.0,"CommonStockSharesOutstanding_0_Q3_shares":52257013.0,"EarningsPerShareBasic_1_Q3_USD":0.54,"EarningsPerShareBasic_3_Q3_USD":1.64,"EarningsPerShareDiluted_1_Q3_USD":0.52,"EarningsPerShareDiluted_3_Q3_USD":1.57,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":96137000.0,"NetIncomeLoss_1_Q3_USD":28011000.0,"NetIncomeLoss_3_Q3_USD":85100000.0,"StockholdersEquity_0_Q3_USD":421936000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":54239847.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":54098330.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":52227630.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":51897240.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS INC","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181109"}]